EnerSys to Acquire Ultralife for $16 Per Share in Cash

What happened

EnerSys agreed to buy Ultralife for $16 per share in cash through a tender offer followed by a merger. The offer is expected to start within 10 business days and needs regulatory clearances and a minimum tender, with no financing condition.

Confirmed

Global impact / market context

Ultralife holders get a fixed cash price of $16 per share instead of continuing to own the stock. Because the deal is all cash, EnerSys will use its own cash or borrowed money, which can reduce cash available for other uses like capital spending.

Analyst inference

Holders with about 40.3% of Ultralife shares already agreed to tender and support the deal, which means a large block is aligned with EnerSys. That support lowers the chance of a rival bid, but the minimum tender condition still needs other holders to participate.

Analyst inference

What to watch

1. The tender offer is expected to commence within 10 business days, and it is subject to customary conditions including regulatory clearances and a minimum tender requirement. Confirmed
2. Certain Ultralife holders with approximately 40.3% of outstanding shares agreed to tender and support the deal, but their shares alone do not meet the minimum tender condition. Proposed
3. Because there is no financing condition, investors can focus on regulatory clearance and how many other Ultralife holders tender, since those determine whether the $16 cash payout closes. Analyst inference

Evidence

• Original source link unavailable